INSIGHTS ON DRUG DEVELOPMENT
-
Increase Throughput For Intact Mass Confirmation And Impurity Screening
Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.
-
Drug Development Plan Explained: DPP Templates And Examples
Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.
-
Accelerate Your pDNA And mRNA Process Development
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Accelerate FDA Approval With Fast Track Designation
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
The QX700: Advanced Digital PCR System3/26/2026
Advanced digital PCR workflows provide precise, standard-free quantification. Maximize insights from small samples with seven-target multiplexing and automated steps to ensure high-throughput accuracy.
-
Why CMC Continuity Is The Missing Link Between Development And Manufacturing9/10/2026
Discover why CMC continuity is the missing link between development and manufacturing, and how preserving connected product and process knowledge helps reduce handoff risk, accelerate tech transfer, and strengthen manufacturing readiness.
-
UPLC-MS/MS Determination Of GLP-1 Analogue7/17/2025
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Predicting Drug-Loading Limits In Tablet Formulations7/15/2026
Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.
-
Patient-Centric Formulations In Pediatric Adherence11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers for children.
DRUG DEVELOPMENT SOLUTIONS
-
Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.
-
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
-
Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.
-
Fluorescent Stereo Microscope Leica M165 FC
The Leica M165 FC fully apochromatic corrected stereo microscope with 16.5:1 zoom optics resolves structures down to 1.1 micron for detailed fluorescent imaging.
Image coding allows easy, convenient reproduction of image settings and parameters for fast, consistent, high quality observation and documentation.
TripleBeam technology dedicates a separate beam channel for fluorescence illumination to enhance image contrast, details and intensity for better performance.
-
Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.